Brief: Certara Simcyp® Simulator Results Replace Ten Human Trials For Chronic Myeloid Leukemia (Cml) Therapy Asciminib
March 3 (Reuters) - Certara Inc CERT.O: CERTARA SIMCYP® SIMULATOR RESULTS REPLACE TEN HUMAN TRIALS FOR CHRONIC MYELOID LEUKEMIA (CML) THERAPY ASCIMINIB Source text: ID:nGNX12MPg3 Further company coverage: CERT.O ((Reuters.Briefs@thomsonreuters.com;))